NEW YORK (360Dx) — Medical & Biological Laboratories has licensed a rapid antibody production method from the University of Toyama in Japan, they announced on Tuesday.

The method called the Magnetic-beads Reaction through Arrayed Hanging-Droplets method, (MAGrahd) allows for the synthesis of an antibody gene from a single antibody-producing cell. Through the licensing agreement, MBL acquired the rights to develop and create high-performance antibodies using the MAGrahd technique worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.